4-Octyl itaconate attenuates radiation-induced intestinal injury associated with ferroptosis inhibition and microbiota rebalance
A compound protects the intestines from radiation damage in mice, offering potential to reduce a serious side effect of cancer treatment.
4-Octyl itaconate was shown to protect against radiation-induced intestinal injury in mice by inhibiting ferroptosis and rebalancing the gut microbiome. This is the first demonstration of 4-OI's protective effects in radiation-induced GI injury, suggesting potential for clinical radioprotection.
What the study was
- Study design
- Preclinical (in vitro + in vivo murine)
- Population
- Mouse model of radiation-induced intestinal injury
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Free Radical Biology and Medicine
Why it surfaced
Off-watchlist (radioprotection, not cancer detection/treatment). Animal model. Novel mechanism but limited immediate clinical relevance to watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.